The Gates Biomanufacturing Facility at CU Anschutz Medical Campus is a 20,000 square ft. GMP compliant facility that provides cell-based therapies and protein biologics for use in preclinical investigations and Phase I and Phase II human clinical trials. The GBF was established through partnership with the Gates Center for Regenerative Medicine, University of Colorado Health, Children's Hospital Colorado, University of Colorado-School of Medicine, and the Gates Frontiers Fund.
Company Details
- Employees
- 47
- Address
- 12635 E Montview Blvd,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- San Francisco.
- HQ
- Aurora, Colorado
Gates Biomanufacturing Facility Questions
Gates Biomanufacturing Facility's website is https://gatesbiomanufacturing.com/
Gates Biomanufacturing Facility's LinkedIn profile is https://www.linkedin.com/company/gates-biomanufacturing-facility
Gates Biomanufacturing Facility has
47 employees.
View email and phone details for 47
employees at Gates Biomanufacturing Facility.
Gates Biomanufacturing Facility's industry is
Biotechnology Research
Gates Biomanufacturing Facility's top competitors are
Parker Institute For Cancer Immunotherapy,
Vertex Pharmaceuticals,
Fitzsimons Innovation Community,
Cu Innovations,
Medtronic,
Cargo Therapeutics,
Affinia Therapeutics,
Akron Bio,
Gates Institute,
Excellos.
Gates Biomanufacturing Facility's categories are Biotechnology Research
